Caelestinus
Overview
Caelestinus is a virtual healthcare incubator, powered by InterSystems, that runs a three-month program supporting startups in AI, interoperability, and medical innovation.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AcuSense BioMedical Technology Corp. | Mar 2023 | Accelerator | Co-investor |
| inTouch | - | Accelerator | Co-investor |
| Genomic Intelligence | Jan 2026 | Accelerator | Co-investor |
| HealthBridge AI | - | Accelerator | Co-investor |
| Tea Leaf Health | - | Accelerator | Co-investor |
For institutional investors. Book with your work email.
Key People
Tomas Studenik
Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Caelestinus based?
Caelestinus is headquartered in Prague, Czech Republic.
When was Caelestinus founded?
Caelestinus was founded in 2022.
How many portfolio companies does Caelestinus have?
Caelestinus has 6 portfolio companies in Caplight's dataset.
What are some companies in Caelestinus's portfolio?
Portfolio companies visible on Caplight include AcuSense BioMedical Technology Corp., inTouch, Genomic Intelligence, HealthBridge AI, Tea Leaf Health.
What was Caelestinus's most recent investment shown here?
Caelestinus's most recent investment in this portfolio sample was in Genomic Intelligence in 2026.
What sectors does Caelestinus focus on?
Caelestinus focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech.
What company stages does Caelestinus focus on?
Caelestinus typically invests at the Early stage.